Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Warfarin for Cerebral Venous Thrombosis
NCT04569279Phase 3Completed
- Sponsor
- Damascus University
- Start
- Sep 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in Cerebral venous thrombosis (CVT), sponsored by Damascus University. Started Sep 2017; status: completed.
02
Drugs
rivaroxaban
03
Conditions
Cerebral venous thrombosis (CVT)
Beyond the preview
Go deeper on NCT04569279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04569279.